CINECA IRIS Institutional Research Information System

BOGAZZI, FAUSTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.924
AS - Asia 6.944
EU - Europa 4.936
SA - Sud America 865
AF - Africa 318
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 28.011
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.456
SG - Singapore 2.138
CN - Cina 2.049
IT - Italia 1.403
HK - Hong Kong 1.386
SE - Svezia 830
BR - Brasile 728
DE - Germania 708
BG - Bulgaria 552
TR - Turchia 404
CA - Canada 354
VN - Vietnam 310
GB - Regno Unito 299
FI - Finlandia 267
UA - Ucraina 260
RU - Federazione Russa 255
KR - Corea 169
IN - India 126
SN - Senegal 118
CH - Svizzera 96
CI - Costa d'Avorio 73
FR - Francia 71
BD - Bangladesh 52
MX - Messico 52
JP - Giappone 51
IQ - Iraq 40
SA - Arabia Saudita 36
AT - Austria 35
ZA - Sudafrica 34
AR - Argentina 31
BE - Belgio 30
NL - Olanda 26
EC - Ecuador 23
VE - Venezuela 22
PK - Pakistan 20
CO - Colombia 19
UZ - Uzbekistan 19
ES - Italia 18
ID - Indonesia 18
PL - Polonia 17
EG - Egitto 16
GR - Grecia 16
KE - Kenya 16
AU - Australia 14
JM - Giamaica 13
DZ - Algeria 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
MY - Malesia 11
PH - Filippine 11
PY - Paraguay 11
UY - Uruguay 11
IE - Irlanda 10
LB - Libano 10
NP - Nepal 10
TT - Trinidad e Tobago 10
AL - Albania 9
BJ - Benin 9
MA - Marocco 9
ET - Etiopia 8
JO - Giordania 8
TN - Tunisia 8
BB - Barbados 7
CL - Cile 7
KZ - Kazakistan 7
OM - Oman 7
DO - Repubblica Dominicana 6
HN - Honduras 6
IL - Israele 6
NG - Nigeria 6
AZ - Azerbaigian 5
EU - Europa 5
PE - Perù 5
BH - Bahrain 4
BO - Bolivia 4
CR - Costa Rica 4
KG - Kirghizistan 4
KW - Kuwait 4
RS - Serbia 4
SY - Repubblica araba siriana 4
BM - Bermuda 3
GT - Guatemala 3
IR - Iran 3
LT - Lituania 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
TH - Thailandia 3
AM - Armenia 2
BY - Bielorussia 2
GY - Guiana 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LY - Libia 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
TW - Taiwan 2
AO - Angola 1
Totale 27.981
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.765
Ashburn 1.578
Fairfield 1.432
Hong Kong 1.273
Singapore 1.093
Ann Arbor 976
Chandler 963
Houston 954
Dallas 657
Seattle 605
Santa Clara 595
Milan 585
Sofia 550
Cambridge 523
Beijing 482
Wilmington 470
Shanghai 432
Jacksonville 356
New York 344
Ottawa 303
Izmir 268
Boardman 260
Hefei 223
Princeton 218
Lawrence 207
Medford 188
Los Angeles 180
Nanjing 174
Seoul 165
Des Moines 136
Dakar 118
Munich 118
Istanbul 109
Bern 95
Serra 88
Dearborn 87
Dong Ket 85
Florence 85
Bremen 84
Nanchang 79
Buffalo 78
Jüchen 77
Abidjan 73
Redondo Beach 70
San Diego 70
Rome 60
Frankfurt am Main 57
São Paulo 55
Turku 55
Kunming 49
Lancaster 48
Ho Chi Minh City 47
Pisa 40
Tokyo 40
San Jose 39
Boulder 38
Changsha 37
Council Bluffs 37
Hebei 35
Tianjin 35
The Dalles 34
Redwood City 33
Shenyang 32
Düsseldorf 30
Columbus 26
Jiaxing 26
Washington 26
Hangzhou 25
London 25
Auburn Hills 24
Brussels 24
Falls Church 24
Ogden 24
Pune 24
Detroit 23
Hanoi 23
Chicago 22
Vienna 22
Dhaka 20
Marseille 20
Rio de Janeiro 20
Falkenstein 19
Norwalk 18
Brasília 17
Guangzhou 17
Quanzhou 17
Belo Horizonte 16
Curitiba 16
Jinan 16
Warsaw 16
Zhengzhou 16
Helsinki 15
Jeddah 15
Tashkent 15
Toronto 15
Nairobi 14
Campinas 13
Johannesburg 13
Mexico City 13
Riyadh 13
Totale 20.764
Salva come PNG Salva come JPEG
Nome #
Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. 235
Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism due to MEN 1-Like syndrome 231
The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type 225
FT-IR Microspectroscopy application in cardiac Hypertrophy 224
Growth Hormone Is Necessary for the p53-Mediated, Obesity-Induced Insulin Resistance in Male C57BL/6J × CBA Mice 206
Glucocorticoid response in amiodarone-induced thyrotoxicosis due to destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations 205
uptake of amiodarone by thyroidal and non-thyroidal cell lines 202
REGULATION OF CARDIAC FATTY ACID METABOLISM IN TRANSGENIC MICE OVEREXPRESSING BOVINE GROWTH HORMONE 202
Effects of Amiodarone, Thyroid Hormones and CYP2C9 and VKORC1 Polymorphisms on Warfarin Metabolism: A Review of the Literature. 197
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 196
Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis 196
More on smoking habits and Graves' ophthalmopathy 190
Graves' disease occurring after subacute thyroiditis: report of a case and review of the literature 190
Primary hyperparathyroidism is associated with marked impairment of GH response to acylated ghrelin 190
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 190
Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis? 188
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 184
AMIODARONE-INDUCED THYROTOXICOSIS AND THYROID STORM 182
The age of patients with thyrotoxicosis factitia in Italy from 1973 to 1996 181
Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study 181
Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study 181
The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis 181
Amiodarone-Induced Thyrotoxicosis 180
Glucocorticoid therapy of Graves' ophthalmopathy 179
Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease 179
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 178
The differentiation-inducing agent sodium butyrate produces divergent effects on albumin and thyroxine-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells 177
Lack of nocturnal serum thyrotropin surge after surgery 175
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 175
Bone and joint alterations in acromegaly 174
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 174
IMPAIRED LEFT VENTRICULAR DIASTOLIC FUNCTION IN ACROMEGALIC PATIENTS WITHOUT CLINICAL SIGNS OF HEART FAILURE: A 2D STRAIN ECHOCARDIOGRAPHIC ANALYSIS 174
Identification, treatment and management of cardiovascular risks in patients with acromegaly 173
Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism 172
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 172
Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy 171
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis 171
Large vestibular aqueduct syndrome: audiological, radiological, clinical, and genetic features 167
Adverse effects of thyroid hormone preparations and antithyroid drugs 166
The mechanisms of nadroparin-mediated inhibition of proliferation of two human lung cancer cell lines 165
Early pre-clinical abnormalities of systolic strain and strain-rate in acromegalic heart: a color Doppler myocardial imaging study 164
Serum Insulin-Like Growth Factor-1 Concentrations Are Reduced in Severely Obese Women and Raise After Weight Loss Induced by Laparoscopic Adjustable Gastric Banding 164
Studies on the occurrence of ophthalmopathy in Graves' disease 162
Graves' hyperthyroidism and ophthalmopathy associated with pemphigus vulgaris: onset of thyroid autoimmune disease during chronic low-dose glucocorticoid therapy 162
Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists 162
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial 162
Lower Prolactin Levels During Cabergoline Treatment are Associated to Tumor Shrinkage in Prolactin Secreting Pituitary Adenoma. 162
A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (Aip) gene in an Italian family with gigantism 162
VITAMIN D STATUS MAY CONTRIBUTE TO SERUM IGF1 CONCENTRATIONS IN HEALTHY SUBJECTS 159
Orbital irradiation in the treatment of Graves' ophthalmopathy 158
Role of orbital radiotherapy in the treatment of Graves' ophthalmopathy 158
A novel mutation in the pendrin gene associated with the Pendred’s syndrome 158
Rare causes of thyrotoxicosis 157
Pendrin does not increase sulfate uptake in mammalian COS-7 cells 157
Surgical treatment of Graves' disease: subtotal or total thyroidectomy? 157
Prevalence and functional significance of antipituitary antibodies in patients with autoimmune and non- autoimmune thyroid diseases 157
Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients 157
The beneficial effect of acromegaly control on blood pressure values in normotensive patients 156
Orbital decompression for severe Graves' ophthalmopathy. Results of a three-wall operative technique 155
Orbital radiotherapy in the treatment of endocrine ophthalmopathy: when and why 155
Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy 155
Long-Term outcome of patients with type 2 amiodarone induced thyrotoxicosis 154
Abnormal expression of PPAR gamma isoforms in the subcutaneos adipose tissue of patients with Cushing's disease 154
Measurement of serum free thyroid hormone concentrations: an essential tool for the diagnosis of thyroid dysfunction 152
Cigarette smoking and the thyroid 150
Prostate-specific antigen is increased in female patients with Cushing's disease 150
COMPARISON OF COLONOSCOPY AND FECAL OCCULT BLOOD TESTING AS A FIRST-LINE SCREENING OF COLONIC LESIONS IN PATIENTS WITH NEWLY DIAGNOSED ACROMEGALY 150
Mutations in the SLC26A4 (pendrin) gene in patients with sensorineural deafness and enlarged vestibular aqueduct 149
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 148
DISEASE ACTIVITY AND LIFESTYLE INFLUENCE COMORBIDITIES AND CARDIOVASCULAR EVENTS IN PATIENTS WITH ACROMEGALY 147
Duration of Exposure to Thyrotoxicosis Increases Mortality of Compromised AIT Patients: the Role of Early Thyroidectomy. 146
Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography 144
Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery 144
Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study 143
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features 143
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly 142
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas 142
Surgical Treatment of Neuroendocrine Tumors of the Pancreas: Results and Prognostic Factors 141
Apoptosis is reduced in the colonic mucosa of patients with acromegaly 141
Abnormal expression of PPAR gamma isoforms in the subcutaneous adipose tissue of patients with Cushing's disease 141
A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator-activated receptor 140
Role of cytokines in the pathogenesis of the euthyroid sick syndrome 140
Ectopic Spleens in the Tail of the Pancreas Mimicking Multifocal Neuroendocrine Tumors in a Patient with History of Endocrine Neoplasia. A Case Report 140
Vitamin D status may contribute to serum insulin-like growth factor I concentrations in healthy subjects 140
Early surgery: a favorable prognosticator in amiodarone-induced thyrotoxicosis-a single-center experience with 53 cases 139
Identification of factors affecting the response to glucocorticoids in patients with amiodarone-induced thyrotoxicosis 138
Cardiac extrinsic apoptotic pathway is silent in young but activated in elder mice overexpressing bovine GH: interplay with the intrinsic pathway 137
Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: a meta-analysis from clinical studies 136
MPAIRED LEFT VENTRICULAR DIASTOLIC FUNCTION IN ACROMEGALIC PATIENTS WITHOUT CLINICAL SIGNS OF HEART FAILURE: A 2D STRAIN ECHOCARDIOGRAPHIC ANALYSIS 135
Peroxisome proliferator-activated receptor (PPAR)γ is highly expressed in normal human pituitary gland 135
Long-term outcome of patients with type 2 amiodarone-induced thyrotoxicosis 134
Tumor Infiltrating Lymphocytes But Not Serum Pituitary Antibodies Are Associated with Poor Clinical Outcome after Surgery in Patients with Pituitary Adenoma 134
ACROSTUDY: the Italian experience 134
[Amiodarone and the thyroid] 132
Amiodarone-induced thyrotoxicosis 131
Does pegvisomant treatment expertise improve control of resistant acromegaly? the Italian ACROSTUDY experience 129
Pegvisomant in acromegaly: an update 128
Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no? 126
Gestione clinica della tireopatia da amiodarone 124
L-thyroxine directly affects expression of thyroid hormone-sensitive genes: regulatory effect of RXRbeta 122
Totale 16.273
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.553
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021829 0 0 0 0 0 0 109 157 117 113 101 232
2021/20222.170 25 89 30 153 482 300 35 102 170 68 107 609
2022/20232.560 324 237 150 304 285 355 9 237 507 7 120 25
2023/20242.165 303 272 334 162 331 369 73 63 24 15 39 180
2024/20256.408 25 241 37 343 431 549 473 398 686 864 668 1.693
2025/20263.780 462 829 790 391 658 632 18 0 0 0 0 0
Totale 28.260